ArticleArthritis care & research2026
Assessment of Pain Types in Recently Diagnosed Patients With Inflammatory Arthritis.
Article in Arthritis care & research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Towards an individualised approach to pain management in inflammatory arthritis.Therapeutic advances in musculoskeletal disease · 2026Review
- Fibroblast-Neuron interactions Driving persistent Pain in Rheumatoid Arthritis (FiND-Pain RA) - an observational study protocol.BMJ open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveUp to 40% of patients with inflammatory arthritis (IA) experience persistent pain, traditionally thought to be associated with a shift from peripherally to centrally mediated pain during the disease course in some patients. We assessed sensory profiles of recently diagnosed individuals with IA, hypothesizing that pain reported at this early stage of diagnosis is driven predominantly by peripheral joint inflammation.
methodsRecently diagnosed patients with IA with pain numerical rating scale scores of ≥3 were recruited. We collected data on the following: arthritis activity (Disease Activity Score in 28 joints [DAS28], musculoskeletal ultrasonography), quality of life (Musculoskeletal Health Questionnaire [MSK-HQ], EuroQol 5-domain), mental health status (Patient Health Questionnaire Anxiety-Depression Scale [PHQ-ADS]), and pain characteristics (fibromyalgia criteria, painDETECT, static and dynamic quantitative sensory testing [QST]).
resultsSixty-one participants (57% female, 62% with rheumatoid arthritis) were enrolled (mean ± SD age 49.8 ± 15 years; mean ± SD time since diagnosis 1.2 ± 2.3 months). Ninety-seven percent had peripheral joint inflammation, with a mean ± SD DAS28 score of 3.8 ± 1. However, 21% met the fibromyalgia criteria, 25% had a painDETECT score of ≥19, and 20% had a tender joint count minus swollen joint count of ≥7, which significantly correlated with DAS28, MSK-HQ, and PHQ-ADS scores. QST revealed lowered pressure pain thresholds at nonarticular sites in a subset of participants and facilitated temporal pain summation and deficient pain modulation in 18% and 61% of patients, respectively.
conclusionThis study provides evidence of centrally mediated pain at the time of diagnosis, challenging the notion that, even at the early stage of disease, pain is driven only by peripheral mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.